BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND TGFBR2, AAT3, 7048, ENSG00000163513, P37173, TGFbeta-RII, RIIC, TAAD2, FAA3, TGFR-2, MFS2, HNPCC6
62 results:

  • 1. Genomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinoma.
    Yang X; Lian B; Zhang N; Long J; Li Y; Xue J; Chen X; Wang Y; Wang Y; Xun Z; Piao M; Zhu C; Wang S; Sun H; Song Z; Lu L; Dong X; Wang A; Liu W; Pan J; Hou X; Guan M; Huo L; Shi J; Zhang H; Zhou J; Lu Z; Mao Y; Sang X; Wu L; Yang X; Wang K; Zhao H
    BMC Med; 2024 Jan; 22(1):42. PubMed ID: 38281914
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Effect of aza-BODIPY-photodynamic therapy on the expression of carcinoma-associated genes and cell death mode.
    Elgun T; Yurttas AG; Cinar K; Ozcelik S; Gul A
    Photodiagnosis Photodyn Ther; 2023 Dec; 44():103849. PubMed ID: 37863378
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Single nucleotide polymorphisms associated with female breast cancer susceptibility in Chinese population.
    Jia Z; Huang Y; Liu J; Liu G; Li J; Xu H; Jiang Y; Zhang S; Wang Y; Chen G; Qiao G; Li Y
    Gene; 2023 Oct; 884():147676. PubMed ID: 37524136
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. GRHL2-controlled gene expression networks in luminal breast cancer.
    Wang Z; Coban B; Wu H; Chouaref J; Daxinger L; Paulsen MT; Ljungman M; Smid M; Martens JWM; Danen EHJ
    Cell Commun Signal; 2023 Jan; 21(1):15. PubMed ID: 36691073
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Risk Factors for Postoperative Bleeding Following breast cancer Surgery: A Nationwide Database Study of 477,108 Cases in Japan.
    Konishi T; Fujiogi M; Shigemi D; Matsui H; Fushimi K; Tanabe M; Seto Y; Yasunaga H
    World J Surg; 2022 Dec; 46(12):3062-3071. PubMed ID: 36155832
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Redistribution of the SWI/SNF Complex Dictates Coordinated Transcriptional Control over Epithelial-Mesenchymal Transition of Normal breast Cells through TGF-β Signaling.
    Jdeed S; Lengyel M; Uray IP
    Cells; 2022 Aug; 11(17):. PubMed ID: 36078038
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. GABPA-activated tgfbr2 transcription inhibits aggressiveness but is epigenetically erased by oncometabolites in renal cell carcinoma.
    Fang Z; Zhang N; Yuan X; Xing X; Li X; Qin X; Liu Z; Neo S; Liu C; Kong F; Björkholm M; Fan Y; Xu D
    J Exp Clin Cancer Res; 2022 May; 41(1):173. PubMed ID: 35549739
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. ALG3 contributes to stemness and radioresistance through regulating glycosylation of TGF-β receptor II in breast cancer.
    Sun X; He Z; Guo L; Wang C; Lin C; Ye L; Wang X; Li Y; Yang M; Liu S; Hua X; Wen W; Lin C; Long Z; Zhang W; Li H; Jian Y; Zhu Z; Wu X; Lin H
    J Exp Clin Cancer Res; 2021 Apr; 40(1):149. PubMed ID: 33931075
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Transcriptomic Profiles of CD47 in breast Tumors Predict Outcome and Are Associated with Immune Activation.
    Noblejas-López MDM; Baliu-Piqué M; Nieto-Jiménez C; Cimas FJ; Morafraile EC; Pandiella A; Corbi ÁL; Győrffy B; Ocaña A
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917174
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. cancer immunotherapy via targeted TGF-β signalling blockade in T
    Li S; Liu M; Do MH; Chou C; Stamatiades EG; Nixon BG; Shi W; Zhang X; Li P; Gao S; Capistrano KJ; Xu H; Cheung NV; Li MO
    Nature; 2020 Nov; 587(7832):121-125. PubMed ID: 33087933
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Coexpression Module Construction by Weighted Gene Coexpression Network Analysis and Identify Potential Prognostic Markers of breast cancer.
    Wang Y; Cui K; Zhu M; Gu Y
    Cancer Biother Radiopharm; 2022 Oct; 37(8):612-623. PubMed ID: 33052716
    [No Abstract]    [Full Text] [Related]  

  • 12. Construction and Analysis of Competing Endogenous RNA Networks for breast cancer Based on TCGA Dataset.
    Wang X; Gao C; Feng F; Zhuang J; Liu L; Li H; Liu C; Wu J; Zheng X; Ding X; Sun C
    Biomed Res Int; 2020; 2020():4078596. PubMed ID: 32775417
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Transforming growth factor beta receptor II (tgfbr2) promoter region polymorphism in Brazilian breast cancer patients: association with susceptibility, clinicopathological features, and interaction with TGFB1 haplotypes.
    Vitiello GAF; Amarante MK; Banin-Hirata BK; Campos CZ; de Oliveira KB; Losi-Guembarovski R; Watanabe MAE
    Breast Cancer Res Treat; 2019 Nov; 178(1):207-219. PubMed ID: 31364002
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Molecular mechanism of miR-153 inhibiting migration, invasion and epithelial-mesenchymal transition of breast cancer by regulating transforming growth factor beta (TGF-β) signaling pathway.
    Wang J; Liang S; Duan X
    J Cell Biochem; 2019 Jun; 120(6):9539-9546. PubMed ID: 30525231
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The c-MYC/NAMPT/SIRT1 feedback loop is activated in early classical and serrated route colorectal cancer and represents a therapeutic target.
    Brandl L; Kirstein N; Neumann J; Sendelhofert A; Vieth M; Kirchner T; Menssen A
    Med Oncol; 2018 Nov; 36(1):5. PubMed ID: 30460421
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A Pan-cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily.
    Korkut A; Zaidi S; Kanchi RS; Rao S; Gough NR; Schultz A; Li X; Lorenzi PL; Berger AC; Robertson G; Kwong LN; Datto M; Roszik J; Ling S; Ravikumar V; Manyam G; Rao A; Shelley S; Liu Y; Ju Z; Hansel D; de Velasco G; Pennathur A; Andersen JB; O'Rourke CJ; Ohshiro K; Jogunoori W; Nguyen BN; Li S; Osmanbeyoglu HU; Ajani JA; Mani SA; Houseman A; Wiznerowicz M; Chen J; Gu S; Ma W; Zhang J; Tong P; Cherniack AD; Deng C; Resar L; ; Weinstein JN; Mishra L; Akbani R
    Cell Syst; 2018 Oct; 7(4):422-437.e7. PubMed ID: 30268436
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. MYEOV functions as an amplified competing endogenous RNA in promoting metastasis by activating TGF-β pathway in NSCLC.
    Fang L; Wu S; Zhu X; Cai J; Wu J; He Z; Liu L; Zeng M; Song E; Li J; Li M; Guan H
    Oncogene; 2019 Feb; 38(6):896-912. PubMed ID: 30181549
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. TGFβ1 regulates HGF-induced cell migration and hepatocyte growth factor receptor MET expression via C-ets-1 and miR-128-3p in basal-like breast cancer.
    Breunig C; Erdem N; Bott A; Greiwe JF; Reinz E; Bernhardt S; Giacomelli C; Wachter A; Kanthelhardt EJ; Beißbarth T; Vetter M; Wiemann S
    Mol Oncol; 2018 Sep; 12(9):1447-1463. PubMed ID: 30004628
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Identification of recurrent risk-related genes and establishment of support vector machine prediction model for gastric cancer.
    Liu B; Tan J; Wang X; Liu X
    Neoplasma; 2018 Mar; 65(3):360-366. PubMed ID: 29788739
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. USP11 Enhances TGFβ-Induced Epithelial-Mesenchymal Plasticity and Human breast cancer Metastasis.
    Garcia DA; Baek C; Estrada MV; Tysl T; Bennett EJ; Yang J; Chang JT
    Mol Cancer Res; 2018 Jul; 16(7):1172-1184. PubMed ID: 29724812
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.